1-15 of 15
Authors: Satoshi Fukasawa
Journal Article
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study Get access
Japanese Journal of Clinical Oncology, hyaf079, https://doi.org/10.1093/jjco/hyaf079
Published: 18 May 2025
Journal Article
Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 12, December 2021, Page 1770, https://doi.org/10.1093/jjco/hyab161
Published: 29 September 2021
Journal Article
Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 11, November 2021, Pages 1656–1664, https://doi.org/10.1093/jjco/hyab114
Published: 04 August 2021
Journal Article
Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study) Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 6, June 2021, Pages 966–975, https://doi.org/10.1093/jjco/hyaa266
Published: 17 February 2021
Journal Article
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study Open Access
Japanese Journal of Clinical Oncology, Volume 50, Issue 7, July 2020, Pages 810–820, https://doi.org/10.1093/jjco/hyaa030
Published: 18 March 2020
Journal Article
Impact of pegfilgrastim as primary prophylaxis for metastatic castration-resistant prostate cancer patients undergoing cabazitaxel treatment: an open-label study in Japan Open Access
Japanese Journal of Clinical Oncology, Volume 49, Issue 8, August 2019, Pages 766–771, https://doi.org/10.1093/jjco/hyz051
Published: 26 April 2019
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study Get access
Japanese Journal of Clinical Oncology, Volume 49, Issue 6, June 2019, Pages 506–514, https://doi.org/10.1093/jjco/hyz026
Published: 22 February 2019
Journal Article
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study Open Access
Japanese Journal of Clinical Oncology, Volume 48, Issue 11, November 2018, Pages 1012–1021, https://doi.org/10.1093/jjco/hyy129
Published: 26 October 2018
Journal Article
Factors predicting biochemical recurrence after radical prostatectomy among patients with clinical T3 prostate cancer Get access
Japanese Journal of Clinical Oncology, Volume 48, Issue 8, August 2018, Pages 760–764, https://doi.org/10.1093/jjco/hyy091
Published: 19 June 2018
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study Open Access
Japanese Journal of Clinical Oncology, Volume 47, Issue 7, July 2017, Pages 639–646, https://doi.org/10.1093/jjco/hyx049
Published: 13 April 2017
Journal Article
Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F] fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate pancer: multicenter Phase IIb clinical trial Free
Japanese Journal of Clinical Oncology, Volume 47, Issue 3, March 2017, Page 283, https://doi.org/10.1093/jjco/hyw177
Published: 05 December 2016
Journal Article
Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study Open Access
Japanese Journal of Clinical Oncology, Volume 46, Issue 11, November 2016, Pages 1031–1041, https://doi.org/10.1093/jjco/hyw103
Published: 24 October 2016
Journal Article
Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial Get access
Japanese Journal of Clinical Oncology, Volume 46, Issue 2, February 2016, Pages 152–162, https://doi.org/10.1093/jjco/hyv181
Published: 04 January 2016
Journal Article
External Validation of a Pre-operative Prognostic Nomogram for Renal Cell Carcinoma in Two Patient Populations: A Retrospective Cohort Study Get access
Japanese Journal of Clinical Oncology, Volume 41, Issue 9, September 2011, Pages 1147–1151, https://doi.org/10.1093/jjco/hyr101
Published: 10 August 2011
Journal Article
Combination of Gemcitabine and Paclitaxel as Second-line Chemotherapy for Advanced Urothelial Carcinoma Get access
Japanese Journal of Clinical Oncology, Volume 39, Issue 4, April 2009, Pages 244–250, https://doi.org/10.1093/jjco/hyp003
Published: 10 February 2009
